Liquidia (LQDA) FCF Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.12 Bn | 160.92 Mn | 56,699.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56,699.00 |
| Mar 31, 2026 | 116,643.00 |
| Dec 31, 2025 | 64,333.00 |
| Sep 30, 2025 | 61,229.00 |
| Jun 30, 2025 | 20,503.00 |
| Mar 31, 2025 | -26,838.00 |
| Dec 31, 2024 | -23,793.00 |
| Sep 30, 2024 | -30,470.00 |
| Jun 30, 2024 | -49,384.00 |
| Mar 31, 2024 | -66,675.00 |
| Dec 31, 2023 | -26,223.00 |
| Sep 30, 2023 | -14,184.00 |
| Jun 30, 2023 | 9,408.00 |
| Mar 31, 2023 | 8,364.00 |
| Dec 31, 2022 | 14,070.00 |
| Sep 30, 2022 | -198.00 |
| Jun 30, 2022 | 3,295.00 |
| Mar 31, 2022 | 12,035.00 |
| Dec 31, 2021 | 161,652.00 |